TY - JOUR T1 - COVID-19: Case fatality and ACE2 inhibitors treatment concerns in patients with comorbidities TT - JF - MJIRI JO - MJIRI VL - 34 IS - 1 UR - http://mjiri.iums.ac.ir/article-1-6799-en.html Y1 - 2020 SP - 1011 EP - 1016 KW - COVID-19 KW - Associated comorbidities KW - Treatment KW - ACE2 inhibitors KW - Type 2 diabetes N2 - The Corona Virus Disease 2019 (COVID-19) outbreak is becoming pandemic with the highest mortality in patients with associated comorbidities. These RNA viruses containing 4 structural proteins usually use spike protein to enter the host cell. Angiotensin-converting enzyme 2 (ACE2) acts as a host receptor for the virus. Therefore, medications acting on renin-angiotensin-aldosterone system can lead to serious complications, especially in patients with diabetes and hypertension. To avoid this, other potential treatment modalities should be used in COVID-19 patients with associated comorbidities. M3 10.47176/mjiri.34.147 ER -